The experimental medication from Palatin Technologies of Cranbury is aimed at an estimated 8 million American women who said they were distressed by their sexual problems
Alexi Friedman/The Star-Ledger, The Times (Trenton)
Sun, 04/20/2014 - 6:01am
The experimental medication from Palatin Technologies of Cranbury is aimed at an estimated 8 million American women who said they were distressed by their sexual problems